INVO Bioscience Inc (NASDAQ:INVO)’s traded shares stood at 0.76 million during the latest session, with the company’s beta value hitting 1.33. At the last check today, the stock’s price was $1.32, to imply a decrease of -13.16% or -$0.2 in intraday trading. The INVO share’s 52-week high remains $10.50, putting it -695.45% down since that peak but still an impressive 62.12% since price per share fell to its 52-week low of $0.50. The company has a valuation of $3.62M, with an average of 3.76 million shares over the past 3 months.

INVO Bioscience Inc (NASDAQ:INVO) trade information

After registering a -13.16% downside in the latest session, INVO Bioscience Inc (INVO) has traded red over the past five days. The stock hit a weekly high of 3.5000, dropping -13.16% in its intraday price action. The 5-day price performance for the stock is 61.96%, and 24.53% over 30 days. With these gigs, the year-to-date price performance is -2.22%.

INVO Bioscience Inc (INVO) estimates and forecasts

Revenue forecast for the current quarter as set by — analysts is -$. Meanwhile, for the quarter ending Sep 2024, a total of — analyst(s) estimate revenue growth to -$.Earnings reports from the last fiscal year show that sales brought in -$ and -$ respectively in the corresponding quarters.

INVO Dividends

INVO Bioscience Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. INVO Bioscience Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.